BULLISHWHALES
BullishWhales · Analysts · Analyst Profile

Annabel Samimy

Stifel · Equity Research Analyst

Analyst rating accuracy & track record

Annabel Samimy does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.

Ratings & price targets

StockRatingPrice targetRated12-mo vs sectorPT hit
LGNDLigand Pharmaceuticals Incorporated
Buy$143.00Apr 2025+87.0%Hit
ALTAltimmune Inc
Buy$18.00Jan 2025−55.8%Miss
GPCRStructure Therapeutics Inc. American Depositary Shares
Buy$50.00Jan 2025+149.9%Hit
IVAInventiva Sa
Buy$17.00Nov 2024+42.6%Miss
MBXMBX Biosciences, Inc. Common Stock
Buy$40.00Oct 2024−27.2%Miss
IVAInventiva Sa
Buy$20.00Sep 2024+238.7%Miss
KMDAKamada
Buy$18.00Jul 2024+47.5%Miss
IVAInventiva Sa
Buy$25.00Feb 2024−21.5%Miss
OCSOculis Holding AG Ordinary shares
Buy$35.00Oct 2023−2.8%Miss
TVRDTvardi Therapeutics, Inc.
Buy$28.00Jun 2023−104.2%Miss
TXMDTherapeuticsMD Inc
Buy$15.00Apr 2020+2.8%Miss
TVRDTvardi Therapeutics, Inc.
Buy$26.00Aug 2018+21.6%Hit
SUPNSupernus Pharmaceuticals Inc
Buy$60.00May 2018−52.0%Hit
TXMDTherapeuticsMD Inc
Buy$17.00Dec 2016−35.7%Miss
Go to

Browse the full analyst leaderboardHow analyst accuracy is scored

Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.

v1.0.30